Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they
stop growing or die. Combining more than one drug may kill more tumor cells. Chemoprotective
drugs such as amifostine may protect normal cells from the side effects of chemotherapy. It
is not yet known which chemotherapy regimen is most effective for children and young adults
with liver cancer. This randomized phase III trial is studying giving combination
chemotherapy together with amifostine to see how well it works compared to combination
chemotherapy alone in treating patients with liver cancer.